Stock Evaluator: Sensus Healthcare, Inc. (SRTS)

Sensus Healthcare, Inc. SRTS

$2.88 -0.01 -0.35%
July 31, 2026 11:42:01 AM EST November 10, 2021 Volume: 2,788
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.

Commentary & Analysis


Financial Summary

Share Statistics SRTS Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $48.1 $334.8 16%
Shares Out (Mil) 16.5 41.7 27%
Institutional Ownership 60.9% 77.3% 39%
Float (Mil) 13.5 34.7 23%
Beta 1.09 0.86 65%
Avg Daily Volume (000s) 22 266 22%
Price Change
(52-week)
(45.2%) 60.7% 18%
Growth SRTS Industry
Median
Percentile
(All Stocks)
Sales (5yr) 23.4% 11.8% 85%
Net Income (5yr) (2.5%) (5.8%) 36%
EPS (5yr) (2.4%) 10.7% 28
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (14.9%) (16.1%) 53%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 3 3 3
Current EPS ($0.110) ($0.330) ($0.090)
Month Ago EPS ($0.097) ($0.293) ($0.017)
# Rev Up 0 1 1
# Rev Down 2 0 0
Three Months Ago EPS ($0.063) ($0.183) $0.063
Year/Year Chg (31.3%) (30.2%) (121.1%)
Financials SRTS Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $23 $152 14%
Net Income (TTM) (Mil) ($8) ($11) 31%
EPS (TTM) ($0.475) ($0.500) 28%
Operating Cash Flow (TTM) (Mil) ($1) ($2) 31%
Net Cash Flow (TTM) (Mil) na $1 na
Long-Term Debt (Q1) (Mil) $0 $22 10%
Enterprise Value (Q1) (Mil) $27 $304 12%
Valuation SRTS Industry
Median
Percentile
(All Stocks)
P/B 1.05 2.88 25%
P/E na 30.5 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.9 na
Ratios SRTS Industry
Median
Percentile
(All Stocks)
Gross Margin 37.7% 59.1% 46%
Net Margin (34.5%) (7.7%) 14%
ROA (13.9%) (13.7%) 23%
ROE (15.8%) (15.9%) 25%
Liabilities to Assets 11.6% 44.9% 7%
F-Score 2 4 7%

Sensus Healthcare, Inc. did not pass any screens on 7/30/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors